Publication Date
1-25-2023
Journal
Journal of the American Chemical Society
DOI
10.1021/jacs.2c09129
PMID
36626587
PMCID
PMC10162582
PubMedCentral® Posted Date
5-5-2023
PubMedCentral® Full Text Version
Author MSS
Published Open-Access
yes
Keywords
Humans, Mice, Animals, Dimerization, DNA, Recombinases, Gene Editing, Genome, CRISPR-Cas Systems, Mammals, PROTAC, CID, inducible gene regulation, mammal, genome editing, AAV delivery
Abstract
Gene regulation via chemically induced dimerization (CID) is useful for biomedical research. However, the number, type, versatility, and in vivo applications of CID tools remain limited. Here, we demonstrate the development of proteolysis-targeting chimera-based scalable CID (PROTAC-CID) platforms by systematically engineering the available PROTAC systems for inducible gene regulation and gene editing. Further, we show orthogonal PROTAC-CIDs that can fine-tune gene expression at gradient levels or multiplex biological signals with different logic gating operations. Coupling the PROTAC-CID platform with genetic circuits, we achieve digitally inducible expression of DNA recombinases, base- and prime-editors for transient genome manipulation. Finally, we package a compact PROTAC-CID system into adeno-associated viral vectors for inducible and reversible gene activation in vivo. This work provides a versatile molecular toolbox that expands the scope of chemically inducible gene regulation in human cells and mice.
Included in
Biological Phenomena, Cell Phenomena, and Immunity Commons, Genetic Phenomena Commons, Medical Biotechnology Commons, Medical Genetics Commons, Medical Specialties Commons
Comments
Associated Data